Table 1.
Overview of authorized regenerative medicine products—a list of allowed cellular, tissue-based, and gene therapy products in the EU, USA, and Japan.
| Product name | Manufacturer | Description | Indication of approval | ![]() |
![]() |
![]() |
|---|---|---|---|---|---|---|
| Imlygic | Amgen Inc. | Gene therapy medicinal product | Unrespectable metastatic melanoma | × | × | |
| Glybera | UniQure Biopharma B.V. | Gene therapy medicinal product | Lipoprotein lipase deficiency with severe pancreatitis | × | ||
| TheraCys | Sanofi Pasteur Limited | Attenuated mycobacteria | Carcinoma in situ of the urinary bladder and Ta and/or T1 papillary tumours | × | ||
| GINTUIT | Organogenesis Incorporated | Allogeneic keratinocytes and fibroblasts in bovine collagen | Mucogingival conditions | × | ||
| TEMCELL | JCR Pharmaceuticals | Allogeneic mesenchymal stromal cells | Acute graft versus host disease | × | ||
| Holoclar | Chiesi Farmaceutici S.p.A. | Autologous corneal epithelial (including stem cells) | Limbal stem cell deficiency with burned corneal damage | × | ||
| PROVENGE | Dendreon Corporation | Activated autologous peripheral blood mononuclear cells | Prostate cancer | × | × | |
| HeartSheet | Terumo | Autologous skeletal myoblast sheet | Chronic ischaemic heart disease | × | ||
| JACE | Japan Tissue Engineering Co. Ltd | Autologous cultured keratinocytes sheet | Full-thickness skin burn wounds | × | ||
| Laviv | Fibrocell Technologies, Inc. | Autologous fibroblast | Nasolabial fold wrinkles | × | ||
| JACC | Japan Tissue Engineering Co. Ltd | Autologous cultured chondrocytes in atelocollagen gel | Traumatic cartilage defects and osteochondritis dissecans | × | ||
| Carticel | Genzyme Biosurgery | Autologous chondrocytes | Acute symptomatic femoral condyle cartilage defects | × | ||
| ChondroCelect | TiGenix N.V. | Autologous cartilage cells | Single-defect symptomatic cartilaginous femoral condyle defects | × | ||
| Maci | Aastrom Biosciences | Autologous chondrocytes | Full-thickness symptomatic cartilage defects | × | ||
| N/A | Bloodworks | CBdHPC | Hematopoietic system deficiency | × | ||
| N/A | LifeSouth Community Blood Centers Inc. | CBdHPC | Hematopoietic system deficiency | × | ||
| N/A | Clinimmune Labs, University of Colorado Cord Blood Bank | CBdHPC | Hematopoietic system deficiency | × | ||
| Ducord | Duke University School of Medicine | CBdHPC | Hematopoietic system deficiency | × | ||
| Hemacord | New York Blood Center, Inc | CBdHPC | Hematopoietic system deficiency | × | ||
| ALLOCORD | SSM Cardinal Glennon Children's Medical Center | CBdHPC | Hematopoietic system deficiency | × |
Marking under the flags indicate approval in corresponding territories.
CBdHPC = cord blood-derived hematopoietic progenitor cells; N/A = not-applicable.


